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Hypertension, a risk factor for aortic valve stenosis, increases transvalvular load
and can elicit extracellular matrix (ECM) remodeling. Elevated cyclic pressure and the
vasoactive agent angiotensin II (Ang II) both promote collagen synthesis, an early
hallmark of aortic sclerosis. It was hypothesized that increased collagen production
induced by elevated pressure conditions or the presence of Ang II would affect the
mechanical properties of leaflet tissue by decreasing extensibility. Porcine aortic valve
leaflets were exposed to pressure conditions of increasing magnitude with and without
Ang II. Biaxial mechanical testing was performed to determine peak stretch. Collagen
content was determined using a quantitative dye-binding method. The results
demonstrated Ang II and elevated pressure decrease the extensibility of leaflet tissue and
increase the collagen content in the ECM. In conclusion, the results demonstrated that
both elevated pressure and Ang II play a role in altering the biomechanical properties of
aortic valve leaflets.
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CHAPTER I
INTRODUCTION

Human Heart Physiology
The heart consists of four chambers: two atria and two ventricles. Their primary
function is to ensure the proper circulation of blood throughout the body through repeated
rhythmic contractions. Deoxygenated blood travels from the body via the vena cava and
collects in the right atrium, which directs blood into the right ventricle. The right
ventricle contracts, pumping deoxygenated blood through the pulmonary arteries and into
the lungs, where it is oxygenated. The newly oxygenated blood collects in the left atrium
via pulmonary veins and is directed into the left ventricle. The left ventricle contracts,
ejecting oxygenated blood through the aorta to the systemic circulation to continue the
cycle. The heart pumps an average of 1-20L of blood per minute [1]. A diagram of the
human heart and blood flow is shown in Figure 1.
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Figure 1.1

Human heart anatomy and blood flow.

(cardiachealth.org).
The cardiac cycle consists of two phases: a single contraction and a single
dilation. Systole refers to ventricular contraction, which causes the ejection of blood, as
shown in Figure 1.2. When ventricular pressure exceeds the pressure in the aorta and
pulmonary artery, blood is forced out of the ventricles through the semilunar valves. As
pressure decreases in the ventricles and becomes greater in the aorta and pulmonary
artery, the semilunar valves close and prevent the backflow of blood into the ventricles.
The closing of the valves signify the end of systole and the beginning of diastole.
Diastole refers to the dilation of the ventricles. During this phase the ventricles relax and
the atrioventricular valves are open, allowing the ventricles to fill with blood from the
atria. When the atrioventricular valves close and pressure begins to build in the
ventricles, the cycle is restarted.
2

Figure 1.2

The heart in diastole and systole

(interactive-biology.com)
The unidirectional flow of blood is achieved by a series of four valves composed
of fibrous tissue: tricuspid valve (TV), pulmonary valve (PV), mitral valve (MV), and
aortic valve (AV). Heart valves are generally believed to open and close passively in
response to the flow of blood and changes in pressure. However, recent evidence has
suggested that the movements of the valve are controlled by interactions between the
components of the valve and the surrounding hemodynamic environment [2]. The
atrioventricular valves, named for their location between the atria and ventricles, consist
of the tricuspid and mitral valves. Collectively known as the semilunar valves, the
pulmonary and aortic valves each consist of three crescent shaped cusps. The pulmonary
valve is located between the right ventricle and pulmonary artery. The aortic valve is
located between the left ventricle and aorta. Of the four heart valves, the aortic valve
3

experiences the harshest hemodynamic environment and is most prone to disease [3,4].
Its unique structure is designed to withstand the demands of the surrounding environment
while sustaining proper function [1].
Aortic Valve Structure
The aortic valve is contained by the aortic root. The aortic root is composed of the
crown-shaped annulus, three sinuses of Valsalva, sinotubular junction, commissures, and
valve leaflets. Each component of the root has its own histological profile and anatomical
design. The coordinated structures function to maintain specific blood flow
characteristics, coronary perfusion, and left ventricular function [1,5]. The area between
each edge of the valve leaflet and aorta is known as the sinus of Valsalva [5]. The leaflets
are referred to as the right coronary, the left coronary, and the non-coronary leaflet based
on their relation to the coronary ostia found in two of the sinuses. Adjacent leaflets meet
at the commissures [6], as shown in Figure 3. Together, the leaflets act as a
hemomodynamic junction between the left ventricle and the aorta [6]. Located below the
free edge of the leaflet is the line of closure and the coapting surface. The lanula is
located above the coapting surface and contains a nodule of fibrous tissue near its center
known as the nodule of Arantius. When the valve closes, the suspended area of the
leaflets flatten and the coapting surfaces meet to separate the left ventricle and the aorta
[5,7,8].
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Figure 1.3

Schematic drawing of aortic root and valve [1].

Aortic valve leaflets are composed of mainly collagen, elastin, and
glycosaminoglycans, which are organized into three layers: the fibrosa, ventricularis, and
spongiosa. Each layer has distinctive mechanical properties and matrix composition. The
fibrosa layer lies adjacent to the aorta and is primarily composed of circumferentiallyoriented collagen. The fibrosa displays great tensile strength and adopts a folded or
crimped formation while under compressive forces. The folds in the fibrosa are
preserved by elastin fibers which encompass and connect collagen fibers [8,9]. The
fibrosa provides most of the tensile strength to the leaflet as the dominant load bearing
layer [10] and constitutes approximately 40% of total leaflet thickness [11]. The
ventricularis is primarily composed of radially-aligned elastin, which contributes to the
elasticity of the valve [10] as shown in Figure 4. The layer is adjacent to the left ventricle
5

and provides a smooth surface for laminar blood flow during systole [8]. The
ventricularis constitutes approximately 30% of the total leaflet thickness [11]. Located
between the fibrosa and ventricularis is the spongiosa and is primarily composed of loose
connective tissue, glycosaminoglycans, and proteoglycans. The spongiosa acts as a shock
absorber and lubrication between the fibrosa and ventricularis during various parts of the
cardiac cycle [9,10,12]. The mechanical characteristics of collagen and elastin contribute
to the continuous preloaded state of the leaflet. The fibrosa layer is under compression
while the ventricularis is under tension. During diastole, the collagen fibers in the fibrosa
unfold and elastin fibers allow the leaflet to extend radially to close the valve. During
systole, the original wavy, folded configuration and orientation of the collagen fibers is
restored as the elastin fibers recoil to open the valve [9].

Figure 1.4

Schematic of aortic valve leaflet layers [5].
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Aortic Valve Cells
The aortic valve leaflet is primarily composed of two cell types; endothelial cells
and interstitial cells. Valvular endothelial cells (VECs) sheath the surface of each leaflet
in a monolayer. The cells are aligned circumferentially and perpendicular to blood flow
[12] and function as an interface between the blood and the leaflets. They are able to
detect variations in shear stress and translate mechanical stimuli into biological responses
[10]. VEC phenotypes are aortic and ventricular -side-dependent and may be determined
by a combination of intrinsic and spatial factors: namely pre-natal development and local
environmental stimuli, such as blood flow characteristics [13,14].
Positioned within the extracellular matrix (ECM) of the leaflets are the valvular
interstitial cells (VICs). VICs are primarily composed of a heterogeneous population of
fibroblasts, myofibroblasts, and smooth muscle cells [10]. These cells are responsible for
organizing and remodeling the leaflet by regulating cell proliferation, migration,
synthesis, and degradation of ECM components that provide its vital mechanical
characteristics [15–17]. Innervation has been observed in the proximal medial sections of
the leaflet [16]. Studies suggest the nerves transmit information between the VECs and
the VICs via signaling mechanisms that are sensitive to changes in the mechanical
environment [16,18]. Five VIC phenotypes have been identified including embryonic
progenitor endothelial/mesenchymal cells, quiescent VICs (qVICs), activated VICs
(aVICs), progenitor VICs (pVICs), and osteoblastic VICs (obVICs) [19]. The qVICs are
fibroblast-like cells that synthesize collagen, elastin, proteoglycans, fibronectin, growth
factors, and matrix metalloproteinases (MMPs). MMPs contribute to maintaining the
structural integrity of the ECM by degrading collagen, elastin, and other proteins. The
7

aVICs are of a myofibroblast phenotype and are characterized by prominent stress fibers
[19,20] and have been implicated in the remodeling of the ECM. Studies have shown in
the ECM of diseased or remodeling leaflets myofibroblasts have significantly increased
in number [17,20]. The pVICs are derived from qVICs and are associated with repair.
The obVICs regulate osteogenesis and are associated with the mediation of calcification
and valve disease [19]. Smooth muscle cells are capable of contraction and contain
secretory properties responsible for maintenance and repair of the ECM [10]. Another
cell phenotype has been shown to actively synthesize collagen as it contains secretory
and synthetic organelles associated with an essential enzyme for stabilizing the collagen
triple helix [20].
Aortic Valve Biomechanics
Although valves are thought to be generally passive structures driven by
surrounding hemodynamics, they also exhibit sophisticated and complex biomechanical
functions. Its structure directly relates to its biomechanical functions. The valve is
composed of resilient and pliable fibrous tissue and designed to meet the demands of
mechanical loading during the cardiac cycle [11].
As the valve opens during systole, leaflets experience flexion as they bend toward
the aortic valve sinuses [21,22]. Elastin fibers in the ventricularis recoil, allowing the
valve to open efficiently [23,24]. Bending stiffness of the leaflet is related to its ability to
effectively open during systole and create a copative seal while closing during diastole
[21,25,26]. When the valve closes during diastole, the leaflets experience biaxial stretch
and compressive strain as a result of the increasing pressure. While under pressure, the
collagen fibers in the fibrosa uncrimp and further align toward the axis of stretch [11,27].
8

Each layer of the leaflet has a distinct response to mechanical loading during the
cardiac cycle. The fibrosa and ventricularis exhibit vastly different mechanical properties,
resulting in an anisotropic tissue behavior [11]. Bending stress during systole is primarily
transmitted by radially-aligned elastin fibers in the ventricularis, while tension is
transmitted by circumferentially-oriented collagen fibers in the fibrosa [11,12]. These
side-specific responses to mechanical loading contribute to the non-linear stress behavior,
viscoelasticity, and biaxial coupling characteristics of the leaflet [28].
When tension is applied in the circumferential direction, the leaflet displays an
elastic behavior as the collagen fibers forgo their wavy configuration and uncrimp
(Figure 1.5). A transitional phase follows and is characterized by the strain as all of the
fibers uncrimp. The final phase is characterized by the total uncrimping and extension of
the collagen fibers. The stiff response in the circumferential direction allows the leaflet to
withstand the increased transvalvular load during diastole [11,29,30]. The response to
loading in the radial direction is dominated by elastin fibers as it contains much fewer
circumferentially-aligned collagen fibers [23]. As a result, the radial direction exhibits a
more gradual response to loading [29,31]. Biaxial mechanical testing has shown that both
the fibrosa and ventricularis are characterized by distinct non-linear, anisotropic
mechanical behaviors. The collagen fibers in the fibrosa dominate the mechanical loading
response to loading while the ventricularis provided a significant contribution to radial
tension [1,11].
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Figure 1.5

Representative circumferential and radial stress–strain curves from a fresh
and fixed aortic valve leaflet, demonstrating the pronounced mechanical
anisotropy of both tissues [31].

Stress relaxation characterizes the transmission of diastolic stress from the leaflet
to the aortic root and influences its fatigue characteristics [32,33]. In addition, it
demonstrates the leaflet’s ability to reorganize its microstructure dynamically. Studies
indicate that aortic leaflet tissue displays a direction-dependent response to stress
relaxation, which is likely a result of structural anisotropy [34].
In diseased valves, the trilayer composition of the leaflet is disrupted as a result of
disorganized protein synthesis and degradation in the ECM [35]. Biomechanical
properties are potentially compromised when structural changes occur as a result of
10

collagen and elastin fiber disorganization and fragmentation [35,36]. In addition,
biological consequences occur as the disorganization of the ECM promotes further
remodeling and repair [35,37].
Mechanical Environment
The aortic valve experiences the harshest mechanical environment of the heart
valves. The intense mechanical environment is regulated by the surrounding
hemodynamic environment. The total stress on the leaflet is tensile throughout the
cardiac cycle [22]. However, during various stages of the cardiac cycle, the aortic leaflets
experience tension, compression, shear, pulsatile, and flexure forces.
The leaflet layers vary in ECM composition; as a result, each layer exhibits
different responses to the application of force. During the cardiac cycle, the belly of
leaflet undergoes changes in three dimensional curvatures, resulting in bending stress. As
the valve begins to close, vortices develop in the sinuses of the leaflet as a result of the
abrupt change in the direction of blood. These vortices and increasing pressure force the
leaflets away from the sinus wall as the leaflets align to form a seal, preventing the
backflow of blood into the left ventricle [28]. The total stress experienced varies
throughout the thickness of the leaflet. The stress in the circumferential direction is
maximal on the ventricular side during diastole at 36 to 75 gm/mm2 and minimal on the
aortic side at 9 to 15 gm/mm2 [22]. During systole, stress in the circumferential direction
is compressive on the ventricular surface at 0.3 to 0.8 gm/mm2 and tensile on the aortic
surface at 4 to 9 gm/mm2 [22].
Leaflets experience side-specific shear stresses during the cardiac cycle [38]. The
ventricular surface is exposed to unidirectional pulsatile shear stress during systole as
11

blood is ejected out of the left ventricle at a peak rate of 1.35 ± 0.35 m/s [39]. During
diastole, the aortic surface experiences oscillatory shear stress as the blood pools into the
sinuses [38,40]. Determining wall and leaflet shear stress values remains a challenge. As
a result, estimates range as low as 15 dynes/cm2 to as high as 1800 dynes/cm2 [40,41].
Strain experienced by the leaflets is dictated by transvalvular pressure (TVP).
TVP acts perpendicular to the leaflet area and is transmitted from the collagen fibers to
the cells in the ECM [2]. The average diastolic TVP under normal hemodynamic
conditions is 80mmHg. TVPs of 100 and 120mmHg signify the classifications of Stage I
and Stage II hypertension, respectively [42]. Strain varies in magnitude and occurs in the
both the radial and circumferential directions.
The aortic valve opens and closes approximately 3x109 times in an average
lifetime [12]. The leaflets undergo stretch in both the radial and circumferential directions
during diastole as they stretch to form a coaptive seal [11,43]. The average elongation is
three times higher in the radial direction than in the circumferential [44].
Altered hemodynamic forces, such as increased shear stress and blood pressure,
have been implicated in the initiation and advancement of aortic valve disease. These
conditions potentially lead to compromised valve structure and function [45].
Cardiovascular Disease
Cardiovascular disease (CVD) affects 1 in 3 Americans and is the leading cause
of death in the United States. CVD encompasses multiple pathologies and ailments
including heart failure, myocardial infarction, stroke, hypertension, arthrosclerosis, and
congenital heart defects [3]. One of the most common surgeries associated with CVD is
heart valve replacement; most notably, aortic valve replacement [3,4,19]. The number of
12

replacement surgeries in the aortic position has steadily increased over the last two
decades [4].
Valvular disease can be acquired or congenital. Acquired disease refers to
conditions that develop in previously healthy valves. Most acquired valve diseases are
age-related degenerative diseases or conditions caused by lifestyle choices [5,12,46].
Congenital conditions develop before birth. These defects include improper leaflet
attachment, incorrect valve size, or malformed leaflets. Bicuspid aortic valves are the
most common congenital heart anomaly in the general population [47]. Approximately
40,000 infants are born with a bicuspid aortic valve each year [48]. The malformation
results in altered hemodynamics and mechanical stress distributions. The altered
mechanical stresses on the valve can eventually lead to calcific deterioration [5,47]. The
average bicuspid valve functions successfully 20 years less than a normal tricuspid valve
[48].
Aortic valve abnormalities are classified as regurgitation, stenosis, or a
combination of both conditions. Regurgitation occurs when the valve is unable to close
completely, resulting in retrograde blood flow into the left ventricle. Aortic valve
sclerosis is a precursor to stenosis. It is described as calcification and thickening of the
valve without a hindrance of blood flow. When aortic sclerosis is present, the risk of
myocardial infarction and death increases by 50% [3]. Aortic valve stenosis refers to the
significant narrowing or obstruction of the valve caused by calcification or scar tissue
(Figure 1.6). In a 2010 study, aortic stenosis was found in 43% of patients with valvular
heart disease [3]. Prevalence of aortic stenosis has shown a strong positive correlation
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with increasing age, high cholesterol levels, smoking, elevated body mass index, and
diabetes [3,49].

Figure 1.6

Normal aortic valve and aortic valve stenosis.

Adapted from intermountainhealthcare.org.
Aortic Valve Disease Pathology
Valvular disease is characterized by inefficiency of the valve due to stenosis
and/or regurgitation. Originally, aortic valve disease was thought to be a passive process
of fatigue and degeneration over time [49]. However, recent studies show that the
pathogenesis of aortic valve disease is regulated by active cell-based processes involving
ECM remodeling, inflammation, lipid deposition, and potential calcification [19,50,51]
(Figure 1.7).
Evidence has shown that calcified aortic valve experience significant ECM
remodeling, regulated by VECs and VICs [19]. Repair and remodeling of the ECM has
been associated with an up-regulation of transforming growth factor (TGF-β) [19].
Homeostasis of the aortic valve ECM is dependent upon the balance between matrix
14

degradation and synthesis maintained by proteolytic enzymes such as MMPs, their tissue
inhibitors (TIMPs), and cathepsins. MMPs regulate collagen turnover, TIMPs inhibit the
effects of MMPs, and cathepsins are associated with the degradation of collagen and
elastin fibers in addition to atherosclerotic plaque progression [52,53]. A disruption in the
delicate balance of these enzymes as a result of altered biomechanical and biochemical
signals can affect the remodeling of the ECM and lead to compromised valve function
[19].
Inflammatory mediators regulate the active process of valvular calcification.
Healthy valves do not contain inflammatory cells such as macrophages and lymphocytes
[49]. Histological studies have confirmed their presence in early calcified lesions
associated with valvular disease, which indicates the initiation of an injury response
mechanism. Proinflammatory cytokines have also been observed in diseased valves [19].
The presence and accumulation of lipids have also been observed in calcific aortic
valve disease [54]. Lipoproteins deposits in aortic lesion and increased aortic valve
cholesterol content have also been associated with the disease. The accumulation of ECM
proteoglycans plays a role in mediating lipoprotein depositions [50].
Calcification contributes to lesion stiffness, potentially compromising the
efficiency of the aortic valve by obstructing blood flow from the left ventricle [54].
Calcification is characterized by calcific deposits of calcium-phosphate minerals, the
accumulation of ECM proteins such as collagen, and the presence of osteopontin, bone
morphogenic proteins, and tenascin C [19,50,55]. Recent studies suggest that the
predominant form of calcification in calcific aortic valve disease is osteogenic
calcification, rather than the passive degenerative process of dystrophic calcification.
15

Osteogenic calcification is an active process regulated by genes associated with cartilage
and bone development [19].

Figure 1.7

Theory of the pathogenesis of calcific aortic valve disease [19].
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Hypertension and Angiotensin II
Studies have shown a positive correlation between hypertension and aortic
stenosis and calcification [42,46,56]. Hypertension is defined as a chronic elevation of
blood pressure caused by a narrowing of arterial walls; this can be caused by blockage,
thickening, or by altered contractile and stiffness responses [42]. The increased
mechanical load hypertension places on the aortic valve has been associated with the
development of aortic calcification and sclerosis [42,57].
It affects approximately one third of the industrialized population [3]. The
development of hypertension may be a result of factors including abnormal functioning
of the heart, vasculature, kidneys, improper diet, smoking, obesity, genetics, or a
combination of multiple factors. Hypertension is a risk factor for other cardiovascular
conditions, such as stroke, heart failure, atherosclerosis, and intracranial hemorrhage
[3,42].
Hypertension can be classified as primary or secondary based on the cause of the
disease [57]. Primary hypertension accounts for 95% of occurrences and etiology remains
unknown [58,59]. Secondary hypertension affects approximately 5% of the population
and has an identifiable cause [60]. The most common causes of secondary hypertension
are endocrine and renal disease. Hypertension is classified by severity in stages: stage 1
hypertension consists of diastolic pressures of 90-99 mmHg, stage II of pressures 100109 mmHg, and stage III exceeds 110 mmHg [61].
Hypertension is associated with multiple organs; however the kidneys play a
major role in the development of the disease [60,62]. Multiple types of renal diseases and
hypertension are commonly linked to an increase in renin secretion. Renal complications
17

and its connection to the renin-angiotensin system (RAS) have been credited as both a
cause and consequence of hypertension [59,63]. The RAS contributes to the regulation of
fluid and blood pressure. Kidney damage compromises its ability to excrete salt and
excess fluid, causing a decrease in renin. A decrease in renin allows for the advancement
of hypertension. An increase in blood pressure can potentially cause further kidney
damage, creating a detrimental cycle of kidney damage and increased blood pressure
[59,63,64]. High levels of renin have been associated with renovascular hypertension
[63]. Renovascualar hypertension causes a decrease in blood flow to the kidneys,
resulting in an increase in blood pressure and potential advancement of hypertension.
In addition to hypertension and renal disease, the RAS has also been implicated in
the progression of atherosclerosis and calcific valve stenosis [64–67]. Angiotensin II
(Ang II) is a potent vasoactive agent and the primary effector of the RAS. The
octopeptide is formed from its precursor Angiotensin I following the cleavage of two
terminal amino acids by the angiotensin-converting enzyme (ACE) [59,68]. Ang II has
been shown to mediate the regulation of vasoconstriction and blood pressure. The
elevated TVP on the leaflet caused by hypertension can activate the renin-angiotensin
system. Ang II has been shown to stimulate collagen type I production in hypertensionassociated aortic diseases [69]. Locally, the physiological effects of Ang II on the AV are
mediated by transforming growth factors such as TGF-β1[70,71] and angiotensin type I
receptors (AT1) [72].
Treatment Options
Typically, by the time valvular disease is clinically detected, it can only be treated
by surgical repair or replacement. The life expectancy of most individuals with severe
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aortic valve stenosis is less than 10 years if left untreated [3]. Valvular repair is a
treatment option that most commonly involves replacing components of the aortic valve
with allogeneic or autologous tissues. The vast majority of treatment methods require
replacing the aortic valve leaflets and/or root altogether. These replacements fall into two
divisions: mechanical and tissue. Mechanical replacements are composed of various
materials but are generally constructed with pyrolytic carbon coated metal [48,73]. While
these replacements are structurally durable, they are not without limitations. Mechanical
replacements contain components and geometries that potentially cause platelet lysis and
protein aggregation on the surface of the valve. The patient incurs considerable lifestyle
restrictions in addition to taking anticoagulant medication for the rest of their lives.
Patients are also at a higher risk for stroke, hemorrhage, and myocardial infarction [74].
Tissue replacement options include xenogenic and allogenic valves. Xenografts
are most commonly obtained from bovine and porcine tissue. These replacements offer
similar physiological hemodynamics, but contain no living cells [48]. Without living
cells, the tissue replacements cannot regenerate or maintain the ECM and may potentially
degenerate over time. Structural deterioration of tissue replacements after implantation
may be affected by tissue preservation, fabrication, chemical fixation, and insertion
techniques of the valve replacements [74].
The Ross Procedure is an autologous tissue replacement option. In this procedure,
the aortic valve or aortic root is replaced with the patient’s own pulmonary valve, while
the patient’s pulmonary valve is replaced with a prosthetic valve. It is commonly
performed in children and young adults (72,73). The pulmonary valve provides suitable
hemodynamic characteristics and low prevalence for thromboembolism and infection
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[75,76]. However, there are considerable limitations. The procedure is extremely
demanding and commonly requires an extensive operation time. Reoperation rates of 1552% beyond 10 years have also been documented [75,77]. In addition, distortion and
malposition of the mobilized coronary arteries have also been reported [75].
Minimally invasive procedures are also becoming common treatment options for
aortic valve disease. For many patients, invasive surgery many not be an option due to
their age, general health, progression of disease, or various other factors. Others may
simply not wish to have surgery for personal reasons [48,78].
Percutaneous aortic valve replacement (PAVR) is a minimally invasive and
relatively new technique, with the first successful implantation reported in 2002 [78].
Implanted valves using this technique usually incorporate a stainless steel or titanium
alloy stent and bovine or porcine pericardial tissue. The valves are most commonly
balloon-expandable or self-expanding. The PAVR is delivered via a catheter guided
through the femoral artery. When the PAVR reaches the aortic valve, the stent expands
and displaces the diseased leaflets (Figure 1.8). In their place lies the new functional
valve [79,80]. Complications with PAVRs include the risk of arterial perforation or
dissection while maneuvering the catheter through vasculature. In addition, embolic
stroke, aortic disruption, and coronary obstruction caused by the native or prosthetic
valve may also occur [79,81,82].
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Figure 1.8

Schematic drawing of the percutaneous aortic valve replacement

A) Positioning of the catheter-mounted valve. B) Dilatation of the device dilatation with a
balloon. C) Correct positioning at the end of the procedure. Adapted from Heinze et al
[80].
Motivation
Aortic valve disease can potentially cause significant problems for not only the
heart, but the entire body. Currently, surgery is the primary treatment option [3,48].
Multiple epidemiological studies have shown a correlation between hypertension and
aortic valve disease [42]. Hypertension affects approximately one third of the
industrialized population [3]. By 2025, the number of adults with hypertension is
expected to increase by 60% [60]. It has been suggested that the excessive pressure
caused by hypertension inflicts additional tension on the leaflets. Over time, the constant
excessive pressure may elicit active cellular responses that promote calcification. The
changes that result in the calcification and thickening of the aortic valve occur in the
ECM. They are caused by active cellular processes that lead to lipid and calcium
deposition and collagen synthesis [36,54]. Multiple studies have investigated the
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structural adaptations in the ECM of the leaflet [17,43,83]. However, the intrinsic
regulations of the biological and mechanical properties that lead to compromised valvular
function are poorly understood. While there are medications on the market to treat
hypertension, current pharmacological approaches to prevent and/or treat aortic valve
disease have not shown consistent success. The results of the current study will help to
provide a better understanding of the biological responses of aortic valves to mechanical
and biochemical changes that occur under hypertensive conditions.
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CHAPTER II
HYPOTHESIS AND SPECIFIC AIMS

Hypothesis
The current study hypothesizes that hypertensive cyclic pressure and/or
angiotensin II decreases extensibility of aortic valve leaflets in a time dependent manner
due to an increase in collagen content and/or interstitial cell stiffness.
Specific Aims
Specific Aim 1: Determine the effects of mechanical and biochemical hypertensive
conditions on the mechanical properties of aortic valve leaflets.
Hypertension and Ang II have both been implicated in aortic valve sclerosis.
Hypertensive pressures and Ang II have been shown to independently increase collagen
synthesis in previous studies [84,85]. As collagen fibers are the main load-bearing
component of the leaflet, hypertensive conditions may affect leaflet extensibility.
Determining the mechanical properties of the leaflets after exposure to hypertensive
conditions will elucidate if hypertensive conditions cause functional changes within the
valve.
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Specific Aim 2: Determine the biological effects of mechanical and biochemical
hypertensive conditions on the ECM that cause the functional changes observed in
SA1.
Thickening and stiffening of the leaflet are signs of aortic valve sclerosis and are
associated with hypertensive conditions. An increase in net collagen content in the ECM
may account for the thickening and dysfunction of the leaflet [43,85]. VICs respond to
altered local stresses transferred from the surrounding ECM and remodel accordingly. A
change in the mechanical properties of the VICs may lead to malfunction in the aortic
valve. Investigating the collagen content and mechanical properties of aortic valve
leaflets may provide a better understanding of the changes in the ECM, resulting in a
better understanding of the changes in mechanical properties observed in Specific Aim 1.
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CHAPTER III
METHODS AND MATERIALS

Tissue Extraction and Culture
Porcine hearts were obtained within 30 minutes of slaughter from a local
slaughterhouse (Sansing Meat Service, Maben, MS). Female Yorkshire/Hampshire pigs
were slaughtered before 6 months of age with a post-slaughter weight of less than 190
lbs. The aortic valve leaflets were excised and transported to the laboratory on ice in
sterile Dulbecco’s phosphate-buffered saline (DPBS, Sigma, St. Louis, MO).
Upon arrival at the lab, leaflets were placed in six well plates (one leaflet per
well) and incubated at 37°C overnight in 3mL (in each well) of Dulbecco’s Modified
Eagle Medium (DMEM, Sigma) supplemented with 10% Fetal Bovine Serum (FBS;
Invitrogen, Carlsbad, CA) and 1% Anti-biotic/Anti-mycotic solution (ABAM; Invitrogen,
Carlsbad, CA). The overnight incubation step was required to insure that all the cells
were synchronized.
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Mechanical and Biochemical Studies
Leaflets were randomly assigned to one of six groups as shown in Table 3.1.
Table 3.1

Aortic Valve Leaflet Experimental Groups
Pressure

0 mmHg

80 mmHg

120 mmHg

Ang II
Ang II ‐ve

Group 1

Group 2

Group 3

Ang II +ve

Group 4

Group 5

Group 6

Group 1 represents static conditions. Group 2 represents normotensive conditions.
Group 3 represents hypertensive mechanical conditions, group 4 static mechanical and
hypertensive biochemical conditions, group 5 hypertensive biochemical conditions, and
group 6 hypertensive mechanical and biochemical conditions. To mimic a biochemical
hypertensive environment, culture media was replaced with fresh media supplemented
with 10-6M Ang II (Sigma). A custom-designed pressure system was utilized to generate
cyclic pressures representative of in vivo normotensive and hypertensive conditions
(Appendix A). The media used in the 6-well plates entering the pressure system was
supplemented with HEPES 25mM (Sigma) to stabilize pH. The leaflets were exposed to
the experimental conditions for 24 and 48 hours and media was replaced every 24 hours.
These durations were chosen as previous studies have shown this to be sufficient time to
observe biomechanical and/or biochemical changes in valve leaflets [84–86].
Biaxial Testing
Biaxial mechanical properties were characterized with a biaxial mechanical
testing system (Figure 3.1). 10mm x 10mm samples of tissue were dissected from the
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central region of the leaflets (Figure 3.2). Four fiducial graphite markers arranged in an
approximately 4 mm x 4 mm square were placed in the center of the extracted portion of
the leaflets to track tissue strain using a CCD camera. Two loops of 000 nylon sutures of
equal length were attached to each side of the samples with four stainless steel hooks.
The samples were mounted on the biaxial device with the radial and circumferential
directions aligned with the x1 and x2 stretch axes of the device, respectively. A membrane
tension (applied force/unit length) was applied along each axis and increased slowly from
a pre-stress tension of ~0.5 N/m to a peak tension of 60 N/m. A peak tension of 60 N/m
was used as it corresponds to the in vivo diastolic pressure.

Figure 3.1

Overhead schematic of a high-speed biaxial testing device

(a) stepper motors; (b) screw-driven linear actuators; (c) load cells; (d) specimen bath
outlet; (e) specimen bath inlet; (f) heating element maintained bath temperature at 37°C;
(g) high-speed digital camera; (h) standard digital camera; (i) beam splitter; (j) subspecimen mirror[87].
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Figure 3.2

Portion of leaflet used for biaxial testing

The samples were preconditioned for ten contiguous cycles, following an
equibiaxial protocol of TCC:TRR = 60:60 N/m, where TCC and TRR are the tensions applied
in the circumferential and radial directions, respectively at 15 seconds per cycle. Tissue
extensibility was characterized by maximum stretch along the circumferential direction
(λCC) and maximum stretch along the radial direction (λRR), at an equibiaxial tension of
60 N/m (A representative tension vs. stretch curve shown in Appendix A).
Collagen Assay
To determine changes in collagen content following exposure to elevated pressure
and/or Ang II, leaflets were prepared as previously discussed with the exception that
leaflets were cut in halves before exposure to the experimental conditions. Paired leaflets
were exposed to –ve and +ve Ang II biochemical conditions and the same pressure
conditions. Following the end of the experiments, the leaflet halves were dehydrated in
an oven at 50°C for 48 hours and the dry masses were recorded. The tissue was dissolved
in pepsin (Sigma) at a concentration of 0.1 mg/ml of 0.5 M acetic acid (Sigma) at 4°C for
48 hours with occasional agitation. The Sircol Collagen Assay (Accurate Chemicals,
Westbury, NY) was used to measure the pepsin-soluble collagen content in the leaflets
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using a quantitative dye-binding method. After the assay was performed, a standard curve
was plotted using the absorbance data from the blank and collagen standard samples. The
slope of the standard curve was used to calculate the collagen content of the test samples.
An R2 value of 0.95 was used as the calibration equation. If R2 value of < 0.95, the assay
was repeated.
Aortic Valve Interstitial Cell Isolation and Culture
Porcine aortic valve leaflets were obtained as previously described. Upon arrival
at the laboratory, leaflets were incubated in sterile collagenase type II (Worthington,
300u/mg) for 10 minutes at 37°C and 5% CO2. Endothelial cells were removed by gently
scraping the leaflet surface with sterile cotton swabs. Remaining leaflet portions were
immediately digested for 8-10 hours in collagenase type II and DMEM with constant
agitation. Digested tissue fragments and cells were centrifuged at 1000 rpm for 5 minutes
and plated in T12.5 cm2 tissue culture flasks. The leaflets were incubated in Dulbecco’s
Modified Eagle Medium supplemented with 10% Fetal Bovine Serum and 1% Antibiotic/Anti-mycotic solution using standard tissue culture methods. Cells were passaged
at 75-85% confluencey and maintained in T75 cm2 flasks. Cells were frozen for longterm storage and recovered as needed for experiments (Protocol outlined in Appendix B).
Cell Mechanics
The interstitial cells were plated into 60 x 15mm petri dishes and exposed to the 6
experimental groups in table 1 for 24 hours. Media was replaced with new media
supplemented with HEPES 25mM to stabilize pH during experimentation. An atomic
force microscope (AFM) was used to evaluate the stiffness of VICs (Veeco Instraments,
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Bioscope Catalyst AFM). Cells were not fixed. Fixation methods potentially kill the cell
and distort its mechanical properties. Measurements were made using a ‘Point-and-shoot’
method in contact mode (Veeco Software). Tip-less cantilevers mounted with 5 μm
diameter polystyrene spheres (Novascan Technologies, Ames, IA) were used. Cantilever
probes were calibrated by thermal vibrations using the manufacture’s software. Spring
constants were calculated as having values between 0.06294 and 0.07148 N/m.
Measurements were performed on 6 cells from each experimental condition, for a total of
36 cells measured. For each VIC, 72 indentions in an 8x9 rectangular grid pattern were
made over the surface of the cell. The Young’s modulus, E, of the cell was calculated
using the Hertz contact model:

√

(3.1)

where E is the Young’s modulus, ν is the Poisson’s ratio, R is the radius of the spherical
indenter, δ is the depth of indentation, and F is the force of indentation. Poisson’s ratio
was set to 0.5 as the cell was assumed to be incompressible.
The relationship between applied force of indentation and indentation depth
(Eq.3.1 and Figure A.4) was fit using the linearized model method for fitting parameters
to a nonlinear equation (NanoScope Analysis, Bruker). Measurement locations with fits
resulting with R2 values of 0.90 were included in analysis. A target depth of
approximately 600nm was used for indentations.
Statistical Analysis
Biaxial mechanical testing and collagen assays were performed 6 times and is
represented as mean ± SD. For all biaxial mechanical testing, the circumferential and
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radial data groups were considered separately. Data underwent two-way analysis of
variance (ANOVA), one-way ANOVA, and t-tests for pairwise comparisons where
appropriate. A P-value of less than 0.05 was considered statistically significant.
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CHAPTER IV
RESULTS

Biaxial Peak Stretch
The results demonstrate that leaflet extensibility of aortic valve leaflet tissue was
greater in the radial direction than in the circumferential direction, which is consistent
with previous studies [30,85].The peak stretches of fresh tissue tested 4 hours after
slaughter were calculated as 1.065±0.031 and 1.399±0.017 in the circumferential and
radial directions, respectively (Figure 4.1). Peak stretch between different time intervals
were statistically similar (p<0.05) in the circumferential direction, as well as in the radial
direction. These results validated the control as peak stretch did not significantly change
during the experiment.
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Figure 4.1

Peak stretch of aortic valve leaflets at various time intervals.

Error bars represent standard deviation (n=6). *denotes significant difference (p<0.05).
When leaflets were incubated with 10-6M Ang II, there was no significant
difference when compared to controls in circumferential direction at either 24 or 48 hours
as shown in Figure 4.2A. However, Ang II significantly reduced peak stretch in the radial
direction at both time intervals (Figure 4.2B).
The elevated pressure of 120mmHg reduced peak stretch in both the
circumferential and radial directions at both time points as shown in Figure 4.3. After 24
hours, the peak stretch of leaflets incubated at both 80 and 120 mmHg was significantly
less than those at 0 mmHg in the circumferential direction (Figure 4.3A). No significant
difference occurred between 80 and 120 mmHg in the circumferential direction. After 48
hours, the peak stretch of leaflets incubated at 120 mmHg was significantly less than
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those at 0 and 80 mmHg. There was no significant difference in leaflets incubated at 0
and 80 mmHg in the circumferential direction after 48 hours.
As can be seen in Figure 4.3B, the peak stretch of leaflets incubated at 120 mmHg
was significantly less than those incubated 0 and 80 mmHg in the radial direction after 24
hours. Leaflets incubated at 0 mmHg were statistically similar (p<0.05) to those
incubated at 80 mmHg. After 48 hours, the peak stretch in leaflets incubated at 120
mmHg was significantly less than those incubated at both 0 and 80 mmHg in the radial
direction. When compared to 80 mmHg, there was no significant difference in leaflets
incubated at 0 mmHg. There was no significant difference between time intervals of
leaflets incubated at the same pressure.
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Figure 4.2

Peak stretch of aortic valve leaflet tissue with and without the presence of
10-6M Ang II at 0 mmHg at various time intervals

A) Circumferential direction. B) Radial direction. Error bars represent standard deviation
(n=6). *denotes significant difference (p<0.05).
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Figure 4.3

Peak stretch of aortic valve leaflet tissue at 0, 80, and 120 mmHg at various
time intervals

A) Circumferential direction. B) Radial direction. Error bars represent standard deviation
(n=6). *denotes significant difference (p<0.05).
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The combination of Ang II and the elevated pressure of 120 mmHg significantly
reduced peak stretch in the circumferential and radial directions at both time intervals. In
the circumferential direction, no significant difference in peak stretch occurred between
the control and leaflets incubated with Ang II at 80 mmHg at either time intervals (Figure
4.4A). In addition, no significant difference was observed in leaflets incubated with Ang
II between 80 and 120 mmHg at either time interval in the circumferential direction.
As can be observed in Figure 4.4B, both 80 and 120 mmHg in combination with
Ang II significantly reduced peak stretch in the radial direction when compared to the
control group at both time intervals. There was no significant difference between leaflets
incubated with Ang II in tandem with 120 mmHg when compared to those with Ang II in
combination with 80 mmHg.
In the circumferential direction, there was no significant interaction between Ang
II and pressure. However, an interaction in between Ang II and pressure was found in the
radial direction as an increase in pressure had an attenuating effect on Ang II.
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Figure 4.4

Peak stretch of aortic valve leaflet tissue at 80 and 120 mmHg incubated
with Ang II compared to control incubated at 0 mmHg without Ang II at
various time intervals

A) Circumferential direction. B) Radial direction. Error bars represent standard deviation
(n=6). *denotes significant difference (p<0.05).
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Collagen Content
Leaflets incubated at 0 mmHg and 80 mmHg had statistically similar (p<0.05)
collagen content when compared to fresh controls (21.77±4.84 µg/mg of dry weight) at
both time intervals as shown in Figure 4.5.

Figure 4.5

Collagen content of aortic valve leaflets at various time intervals

Error bars represent standard deviation (n=6). *denotes significant difference (p<0.05).
When leaflets were incubated with 10-6M Ang II, the collagen content was
significantly greater than those incubated under the same pressure condition without Ang
II at both time intervals (Figure 4.6). At both time points, the collagen contents of leaflets
incubated with Ang II at 80 mmHg and 120 mmHg were significantly greater than those
at 0 mmHg without Ang II. The collagen content of leaflets incubated with Ang II at 24
hours was significantly similar to those without Ang II under the same pressure condition
after 48 hours.
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Figure 4.6

Collagen content of leaflet tissue at 0, 80 and 120 mmHg incubated with
Ang II compared to those incubated without Ang II under same pressure
condition and to 0 mmHg (-Ang II) controls

A) 24 hour interval. B) 48 hour interval. Error bars represent standard deviation (n=6).
*denotes significant difference (p<0.05).
As can be seen in Figure 4.7, the collagen content of leaflet tissue incubated at 80
mmHg were stastically simimlar (p<0.05) to those at 0 mmHg at 24 and 48 hours. There
was a significant increase in collagen content in tissuse incubated at 120 mmHg when
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compared to those at 0 and 80 mmHg at both time intervals. At 48 hours, there was a
significant increase in tissue incubated at 120 mmHg when compared to 24 hours under
the same pressure conditon. No significant interaction was observed between Ang II and
pressure.

Figure 4.7

Collagen content of leaflet tissue at 0, 80, and 120 mmHg at 24 and 48 hour
intervals

Error bars represent standard deviation (n=6). *denotes significant difference (p<0.05).
Cell Mechanics
As can be observed in Figure 4.8, the Young’s modulus of VICs incubated at 120
mmHg was significantly lower than those incubated at 0 and 80 mmHg. There was no
significant difference between cells incubated at 0 and 80 mmHg.
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Figure 4.8

Young’s moduli of aortic valve interstitial cells after 24 at 0, 80, and 120
mmHg

Error bars represent standard deviation (n=7). *denotes a significant difference (p<0.05).
ANOVA results demonstrate that VICs incubated with Ang II had a significantly
higher Young’s modulus than those without Ang II at the same pressures (Figure 4.9).
VICs incubated in Ang II had a significantly higher modulus than those without the
vasoactive agent at 0 mmHg and 80 mmHg after 24 hours. There was no significant
difference between VICs incubated with Ang II at 80 mmHg verses those incubated
without Ang II at the same pressure. A significant interaction was observed between Ang
II and pressure as normal pressure had an attenuating effect on Ang II.
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Figure 4.9

Young’s moduli of aortic valve interstitial cells after 24 hours at 0, 80, and
120 mmHg with and without the presence of Ang II

Error bars represent standard deviation (n=7). *denotes significant difference (p<0.05).
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CHAPTER V
DISCUSSION

Blood pressure is a critical factor in the harsh mechanical environment of the
aortic valve. Valve leaflets must endure dynamic and complex mechanical forces
generated by TVP gradients during the cardiac cycle. The biomechanical properties of the
aortic valve leaflet are therefore critical for proper valve function. A decrease in leaflet
extensibility may provide protection from prolapse that often occurs as a result of
hypertension and aortic valve disease. However, an excessive increase in collagen
production may be damaging to the valve and cause a progression of valve disease. Ang
II and elevated pressure have both been implicated in valve disease and collagen
synthesis. The results demonstrate that elevated pressure and Ang II are critical to and
can alter the biomechanical properties of aortic valve leaflet tissue.
The results of the current study support previous findings [11,44,88] as the peak
stretch of fresh leaflet tissue at 60 N/m was greater in the radial direction than in the
circumferential direction. Primarily circumferentially-oriented collagen fibers in the
fibrosa layer are the major load-bearing component of the leaflet. When the leaflet is
stretched in the circumferential direction, collagen fibers align and the tension in the
fibers resist further stretching. When the leaflet is stretched in the radial direction,
collagen fibers separate and provide less resistance [88]. It is this architecture that largely
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defines the distinct responses to biaxial tension in the circumferential and radial
directions.
After 24 hours, leaflets incubated with 10-6 M Ang II at 0 mmHg (static
atmospheric pressure) had a significantly reduced peak stretch in the radial direction at
both time intervals when compared to leaflets incubated without the vasoactive agent.
The reduction in peak stretch shows a reduction of extensibility of the leaflet due to the
presence of Ang II. In previous studies [71,89], Ang II has been shown to increase
collagen synthesis. Ang II exerts its effects on interstitial fibroblasts in the leaflet
through AT1 receptors [49] and the induction of the transforming growth factor, TGF-β1
[70,90]. Fibroblasts in healthy leaflets do not express AT1 receptors; the receptors are
expressed by fibroblast lesions. The receptor is activated when Ang II is present [49]. The
decrease in extensibility exhibited by the leaflet inversely relates to the significant
increase in collagen content observed in leaflets incubated with 10-6 M Ang II at static
atmospheric pressure when compared to those without Ang II. In addition to collagen
synthesis, Ang II has also been shown to mediate collagen degradation in human [91] and
rat [92] cardiac fibroblasts by decelerating interstitial collagenase activity via TIMP-1
production in endothelial cells [93]. This finding implies that an increase in collagen
content caused the decrease in leaflet extensibility by initiating collagen synthesis and/or
inhibiting collagenase activity.
Although extensibility decreased in the radial direction after 24 hours, leaflets
incubated with and without Ang II were statistically similar in the circumferential
direction. A previous study reported that the vasoactive agent, 5-hydroxytryptamine,
increased the elastic modulus of aortic valve leaflet tissue in the circumferential direction,
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while Ang II caused an increase in the radial direction [84]. In addition, a study by
Simmons et al., demonstrated that gene expression can be side-dependent on porcine
aortic valves. The results of the current study may be related to side-specific response
mechanisms of Ang II on the leaflet tissue. The effect of Ang II on collagen production
may be specific to the ventricularis layer of the valve. The collagen fibers in the fibrosa
are primary oriented in the circumferential direction, however, the ventricularis contains
radially-aligned collagen fibers [24,27]. In addition, calcific aortic valve disease may
cause the disorganization and fragmentation of collagen fibers in the ventricularis and
fibrosa layers [35]. Disorganization and/or an increase in collagen production in radiallyoriented fibers in the ventricularis may explain the decrease in extensibility found only in
the radial direction.
Biaxial testing shows that the cyclic pressure of 120 mmHg (hypertensive
pressure) caused a significant reduction in leaflet extensibility in the circumferential and
radial directions at both time intervals. These findings highlight an inverse relationship
between extensibility and the increase in collagen content in leaflets exposed to
hypertensive pressure when compared to those at static atmospheric pressure. The results
are in agreement with a previous study investigating the effects of cyclic and static
pressure on aortic valve leaflets that showed that hypertensive pressure caused a
proportional increase in collagen synthesis in leaflet tissue [85]. Elevated pressure exerts
compressive force on the leaflets [83]. As collagen is the main load bearer of the force
created by pressure, it is plausible that higher pressure causes a greater need for collagen
in order to adapt to harsher mechanical conditions. Multiple mechanisms have been
implicated in the aortic valve’s response to pressure. Elevated pressure may cause
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changes collagen content in the leaflet by direct mechanotransduction. In addition,
pressure may affect the ECM synthesis indirectly by utilizing paracrine factors released
by endothelial cells on the leaflet surface [85].
After 48 hours, leaflets incubated at the cyclic pressure of 80 mmHg
(normotensive pressure) had similar extensibility to those incubated at static atmospheric
pressure in both directions. These results follow the trend of collagen content findings
under the same conditions. After 24 hours, the extensibility of leaflets incubated at
normotensive pressure was less than those incubated at static atmospheric pressure in the
circumferential direction. These results do not agree with collagen content findings. The
collagen content in leaflets incubated at normotensive pressure was statistically similar to
those incubated at static atmospheric pressure for 24 hours. However, in the radial
direction, leaflets incubated at normotensive pressure were significantly similar in
extensibility and collagen content when compared to static atmospheric pressure after 24
hours. While these results imply that collagen content may not be the only factor in the
leaflets’ response to a change in cyclic pressure, it is important to note that the collagen
assay used in the current study only accounts for pepsin soluble collagen. Salt soluble,
acid soluble, and insoluble collagen [88] may play a role in leaflet tissue extensibility. In
addition, the findings introduce the possibility of cyclic pressure playing specific roles in
the extensibility of tissue in individual layers of the leaflet.
The combination of Ang II and hypertensive pressure significantly reduced
extensibility in the circumferential and radial directions after 24 and 48 hours. These
results inversely relate to collagen content findings under the same conditions. In
addition, the extensibility of leaflets exposed to the combination of Ang II and
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hypertensive pressure did not significantly differ from those exposed to hypertensive
pressure alone in either direction. In the circumferential direction, the extensibility of
leaflets incubated with Ang II at normotensive pressure was statistically similar to those
incubated without Ang II at static atmospheric pressure at both time intervals. These
findings are in agreement with results that showed Ang II had no effect on extensibility in
the circumferential direction. These findings also agree with results that indicated
normotensive pressure had little effect on the extensibility of leaflets when compared to
those at static atmospheric pressure.
In the radial direction, leaflets incubated at normotensive pressure with Ang II
showed less extensibility than those at static atmospheric pressure without the presence of
Ang II at both time intervals. These results are in agreement with findings that show Ang
II alone was capable of decreasing leaflet tissue extensibility in the radial direction.
Leaflets incubated at normotensive pressure with Ang II were statistically similar to those
at hypertensive pressure with Ang II at both time points in the radial direction. These
findings indicate that the presence of Ang II had more of an effect on leaflet tissue
extensibility in the radial direction than hypertensive pressure when used in combination.
Normotensive pressure in combination with Ang II had no effect on extensibility in the
circumferential direction while it did produce a reduction in extensibility in the radial
direction. This finding further suggests a side-specific response to Ang II. The collagen
content of leaflets incubated at normotensive pressure with the addition of Ang II was
significantly greater than those at static atmospheric pressure without Ang II at both time
points. These findings further imply that disorganized collagen fibers and collagen of
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different stages may play a role in the leaflets’ response to cyclic pressure and Ang II
[35,88].
Ang II proved to have more influence on the extensibility of leaflet tissue than
hypertensive pressure in the radial direction. However, there was no significant
difference in collagen content between leaflets incubated at static atmospheric pressure in
the presence of Ang II verses those incubated at hypertensive pressure without Ang II.
These findings suggest that Ang II may affect more than collagen synthesis alone in
aortic valve leaflets. Previous studies have reported that Ang II can elicit contractions in
arterial smooth muscle cells [59,66] and equine aortic valve leaflets [94]. However, it is
unclear if interstitial cell contractions could be responsible for a significant increase in
extensibility after the prolonged periods 24 and 48 hours.
Overall, peak stretch was statistically similar after 48 hours when compared to 24
hours in both directions. With the exception of leaflets exposed to hypertensive pressure
without the presence of Ang II, the collagen contents of leaflets incubated for 24 hours
were statistically similar to those incubated for 48 hours under the same conditions. The
net collagen content of the leaflet tissue is regulated by the balance between newly
synthesized and degraded collagen. The amount of collagenases such as MMPs and
cathepsin L in the ECM has been shown to be affected by hypertensive pressure [95]. In
leaflets incubated with Ang II, the increase after the initial 24 hour incubation may be due
to collagen synthesis occurring at a faster rate than degradation. After 48 hours of
incubation, MMPs may increase in an attempt restore homeostasis in the ECM resulting
in a similar net amount of collagen.
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The VICs of aortic leaflets play a major role in the remodeling and organization
of the ECM. Altered mechanical and/or biochemical conditions on the leaflet to the VICs
may cause a series of changes in the composition and structure of the ECM, potentially
modifying the functionality of the leaflet [96,97].
Cell elasticity is primarily the result of the intrinsic properties of the cell
membrane and cytoskeleton. Intracellular components of the cytoskeleton include actin
fibers, intermediate fibers, and microtubules. The reorganization of cell organelles and
these structural components each play a role in cell stiffness [98,99]. The Young’s
modulus of VICs incubated under hypertensive pressure was significantly lower than
those incubated at static atmospheric and normotensive pressures. These results contrast
with those stating that cell stiffness increases in proportion to the level applied
mechanical stress [15,100]. However, little is known regarding aortic VICs response to
altered TVP. The current results also contrast with a study by Merryman et al. that
reported VICs from the pulmonary valve were less stiff than those isolated from the
aortic valve [15]. The stiffness of the cells showed a positive correlation to the
transvalvular pressures of the valves. These findings suggest that an increase in TVP
causes increased VIC stiffness. In the current study, the VICs were exposed to altered
mechanical and biochemical conditions for 24 hours. The suddenly altered environment
may have caused different responses in the cytoskeleton than those of extended time in
normal hemodynamic environments. In addition, the multiple cell types found in the
ECM of the aortic valve and their individual responses to pressure may also play a
critical role in the overall VIC stiffness [98] under normotensive and hypertensive
pressure conditions.
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Following a trend similar to hypertensive pressure alone, VICs incubated with
Ang II at hypertensive pressure also displayed a lower modulus than those incubated with
Ang II at static atmospheric pressure. However, the stiffness of cells incubated with Ang
II was greater than those incubated without the vasoactive agent under the same pressure
conditions. These results imply that the addition of biochemical hypertensive conditions
may have altered the intracellular components and/or cell membrane of the VICs to a
configuration that provided greater cell stiffness.
VICs did not follow the general trends of the biaxial and collagen content results.
The VICs exposed to static atmospheric pressure showed a decrease in stiffness when
compared to hypertensive pressure alone and in combination with Ang II. The results
suggest an inverse relationship between leaflet stiffness and VIC stiffness. Studies have
also shown that apoptosis occurs more in statically cultured conditions than in ex vivo
organ culture systems that simulate aortic valve hemodynamic environments [101]. In
addition, studies have suggested that apoptosis occurs proportional to the level of applied
stress in cells [102]. These results imply that a lack of native mechanical stimulation may
be detrimental to health of VICs. An apoptotic response to increased cyclic pressure with
and without the presence of Ang II may play a role in the stiffness of VIC.
Another important factor to consider in these findings is the lack of ECM and
VECs in VIC culture. VECs on the surface of the leaflet are responsible for detecting
variations in the mechanical and biochemical environments of the aortic valve. The cells
translate mechanical and biochemical stimuli into signals to communicate with VICs in
the ECM. The communication between VECs and VICs plays a critical role in the
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homeostasis of the ECM [14,35,103]. A disruption in normal cell-to-cell communication
may affect VIC response to hypertensive mechanical and biochemical conditions.
A major limitation to this study was the lack of additional mechanical forces such
as stretch and shear that are normally experienced by the aortic valve hypertensive
conditions. Stretch has been shown to induce cell proliferation, apoptosis, collagen
synthesis and changes in valve biomechanical properties [43]. Shear stress regulates
common features of aortic valve disease such as inflammation and calcification [2].
These mechanical forces affect the composition and homeostasis of the ECM.
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CHAPTER VI
CONCLUSIONS AND FUTURE STUDIES

Conclusion
The focus of this study was on the effects of elevated cyclic pressure and Ang II
on the biomechanical properties of aortic valve leaflets. Changes in aortic valve
biomechanical properties may give insight to the ability to withstand altered biochemical,
mechanical, and hemodynamic forces associated with hypertension. In the current study,
Ang II and elevated pressure have affected the biomechanical properties and ECM
composition of the aortic valve leaflet. Results show that elevated cyclic pressure reduced
the extensibility of leaflet tissue. Ang II produced direction-specific changes in leaflet
extensibility, implying that different mechanisms are utilized in the layers of the leaflet.
Elevated pressure and Ang II produced increases in collagen content in the ECM when
used independently and in tandem. A decrease in VIC stiffness was noted when exposed
to elevated pressure and Ang II. These findings may aid in the understanding of adaptive
responses of aortic valve biomechanical properties and provide insight to create more
successful pharmacological approaches to prevent and treat aortic valve disease.
Future Studies
The current study shows that elevated pressure and Ang II affect the Young’s
modulus of VICs. However, the science as to how hypertensive conditions affect cell
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stiffness remains unclear. A further approach might be to determine the effects of
elevated pressure and Ang II on the cytoskeleton of aortic VICs. This information may
provide a better understanding of how hypertensive conditions affect the Young’s
modulus of VICs. Further work may also be done on the understanding of the signaling
pathways that are important in VEC to VIC mechanotransduction. VECs on the surface
of the leaflet are sensitive to hemodynamic and mechanical changes in their environment.
Their primary functions are to sense and communicate stimuli to the VICs. A better
understanding of VEC-VIC communication in in response to elevated pressure and Ang
II may provide a better understanding of the cells’ role in calcific aortic valve disease.
In addition, future work on the signaling pathways of Ang II associated with
aortic valve calcification would be beneficial to understanding the direction specific
response in extensibility of Ang II.
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APPENDIX A
PRESSURE SYSTEM SCEMATIC AND REPRESENTATIVE CURVES
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Figure A.1

Pressure System Schematic.

*Average temperature inside pressure chamber, 35.9°C.
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Figure A.2

Graph of pressure simulation within bioreactor

A) normal and B) hypertensive pressure conditions.
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Radial

Figure A.3

Representative tension vs. stretch biaxial mechanical testing curve.

Figure A.4

Force vs. separation (indentation depth) (blue curve) from a single
indentation of an aortic valve interstitial cell with AFM.
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APPENDIX B
PROTOCOLS
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VIC Cryopreservation and Recovery
Cell Freezing
1. Remove old culture medium and rinse with sterile PBS.
2. Add Trypsin to the flask and incubate for 5 minutes.
3. Add an equal amount of culture medium and place in a centrifuge tube.
4. Centrifuge for 5 minutes at 1000 RPM
5. Remove the supernatant from the centrifuge tube.
6. Re-suspend pellet in 10% DMSO in FBS to give desired freezing cell concentration.
7. Aliquot suspension into cryo vials.
8. Place vials in pre-chilled Nalgene Mr. Frosty and place in -80°C freezer overnight.
9. Remove vials from Mr. Frosty and place in -80°C liquid nitrogen.
Cell Recovery
1. Remove vials from -80°C and place them in a 37°C water bath until semi thawed.
2. Gently re-suspend cells in solution.
3. Place solution into a centrifuge tube.
4. Add 9ml of DMEM/ 10% FBS / 10% ABAM.
5. Re-suspend cells in solution.
6. Centrifuge for 5 min at 1000 RPM.
7. Remove the supernatant from the centrifuge tube.
8. Re-suspend in culture medium and place in T-25 flask.
9. Replace media within 24 hours.
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Table B.1

Reagents for Cell Culture and Cryopreservation

Reagent
Dulbecco’s Modified Eagle’s Medium (DMEM)
Fetal Bovine Serum (FBS)
Antibiotic/Antimycotic (ABAM)
Trypsin EDTA
T‐12.5 Flasks
T‐25 Flasks
T‐75 Flasks
Swabs
Syringe Filters
Syringes
Collagenase Type II
Filter Bottles
Dulbecco’s Phosphate Buffered Saline (PBS)
Dimethyl Sulfoxide (DMSO)
Freezer Vials
Nalgene Mr. Frosty

Company
Sigma
Invitrogen
Gibco
Gibco
BD Falcon
BD Falcon
BD Falcon
Texwipe
VWR
BD Falcon
Gibco
Corning
Sigma
Sigma
VWR
Sigma

Catalog Number
D5796
10437‐028
15240
25300
353107
353109
353136
TX761
28145‐477
309654
17101‐015
430769
D5652
D2650
89094‐810
C1562

Sircol Collagen Assay
Procedure:
1. Digest tissue in pepsin dissolved in 0.5M acetic acid (buffer) for 48 h at 50°C at
concentration of 0.1ml/mg of 0.5M acetic acid with occasional agitation.
2. Add 1ml of samples to 100μl acid neutralizing reagent.
3. Add 200μl of cold isolation and concentration reagent to each tube.
4. Mix tube contents by tube inversions.
5. Place tubes in ice-water mix and incubate overnight at 4°C.
6. Centrifuge tubes at 12,000 rpm for 10 minutes.
7. Use a micropipette to remove 1000μl of supernatant from each tube.
8. Prepare reagent blanks (100 μL deionized water) and collagen standards (duplicates
containing 15, 30, 60 μg).
9. Add 1 mL Sircol Dye reagent to each tube.
10. Place tubes in a mechanical shaker for 30 min.
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11. Transfer tubes to a microcentrifuge and spin at 12,000 rpm for 10 minutes.
12. Invert tubes to drain the unbound dye.
13. Add 750μl of ice-cold acid-salt wash reagent to each tube to remove unbound dye
from the surface of the pellet and inside of the tube.
14. Centrifuge and spin at 12,000 rpm for 10 minutes.
15. Add 250μl alkali reagent and mix.
16. Transfer 200μL aliquots of samples from tubes to a 96-well multi-well plate.
17. Place the plate in a microplate reader, read the absorbance at 555 nm.
Table B.2

Reagents for Collagen Assay

Reagent
Pepsin
Acetic acid 0.5 M
Sircol collagen assay kit

Company
Sigma
Sigma
Accurate Chemical
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Catalog Number
P7012
A8976
CLRS1000

